Tenet Healthcare Corporation New insider trading
THCfinancial statementsForm 4 filings on EDGAR193 transactions since Nov 1, 2024
From August 4, 2026 to November 1, 2026, 0 insiders at Tenet Healthcare Corporation New bought $0 of stock in the open market, and 8 sold $43M. Officers and directors accounted for $0 of purchases and $43M of sales. The last reported transaction was an open-market sale by Kerrey J Robert on September 14, 2026.
The answer card and chart use the same period. Change the range above the chart to update both. Form 4 filings through September 16, 2026; awards, option exercises, tax withholding and gifts are excluded from these totals.
Stock price and insider activity
Daily price candles with insider purchases and sales directly beneath them on the same timeline. Bars show individual days; totals sum all days in the selected period.
Bought $0Sold $43MAug 4, 2026 – Nov 1, 2026
purchases above zero; sales below. Both use the transaction date and the same dollar scale. Hover, tap, or use arrow keys to inspect a date. Awards, exercises, tax withholding and gifts are excluded.
Dates with prices or insider activity are spaced evenly; empty weekends and holidays are omitted. Prices through Oct 30, 2026. Insider data through Nov 1, 2026. Prices are adjusted for splits; transaction values are reported dollars.
Every transaction
193 transactions from November 1, 2024 to November 1, 2026, newest first. Open-market purchases and sales are coloured; awards, exercises, tax withholding and gifts are grey and not counted.
| Traded | Insider | Role | Transaction | Shares | Price | Value | Held after | Filed |
|---|---|---|---|---|---|---|---|---|
| Sep 14, 2026 | Kerrey J Robert | Director | open-market sale | 5,483 | $263.04 | $1M | 11,321 | Sep 16, 2026 |
| Sep 14, 2026 | Kerrey J Robert | Director | open-market sale | 4,025 | $264.10 | $1M | 7,296 | Sep 16, 2026 |
| Sep 14, 2026 | Kerrey J Robert | Director | open-market sale | 2,502 | $264.62 | $662K | 4,794 | Sep 16, 2026 |
| Sep 10, 2026 | Mark Richard J | Director | open-market sale | 10,000 | $263.42 | $3M | 25,121 | Sep 14, 2026 |
| Sep 2, 2026 | West Nadja | Director | open-market sale | 1,152 | $258.80 | $298K | 23,653 | Sep 3, 2026 |
| Aug 31, 2026 | Foo Lisa Y | EVP, Chief Operating Officer | open-market sale | 24,000 | $266.32 | $6M | 8,053 | Sep 1, 2026 |
| Aug 28, 2026 | Haney Cecil D | Director | gift | 150 | $0.00 | — | 12,403 | Aug 31, 2026 |
| Aug 25, 2026 | Sutaria Saumya | CEO, Director | open-market sale | 17,220 | $273.34 | $5M | 466,344 | Aug 26, 2026 |
| Aug 25, 2026 | Sutaria Saumya | CEO, Director | open-market sale | 24,881 | $274.10 | $7M | 441,463 | Aug 26, 2026 |
| Aug 25, 2026 | Sutaria Saumya | CEO, Director | open-market sale | 7,899 | $275.26 | $2M | 433,564 | Aug 26, 2026 |
| Aug 24, 2026 | Haney Cecil D | Director | open-market sale | 1,300 | $278.03 | $361K | 12,553 | Aug 26, 2026 |
| Aug 24, 2026 | Sutaria Saumya | CEO, Director | open-market sale | 13,344 | $278.17 | $4M | 520,220 | Aug 26, 2026 |
| Aug 24, 2026 | Sutaria Saumya | CEO, Director | open-market sale | 36,656 | $278.90 | $10M | 483,564 | Aug 26, 2026 |
| Aug 7, 2026 | Romo Tammy | Director | open-market sale | 2,500 | $260.83 | $652K | 28,284 | Aug 10, 2026 |
| Aug 6, 2026 | Romo Tammy | Director | open-market sale | 4,922 | $264.15 | $1M | 30,784 | Aug 10, 2026 |
| Aug 5, 2026 | Blunt Roy | Director | open-market sale | 600 | $262.68 | $158K | 4,589 | Aug 7, 2026 |
| Jul 29, 2026 | Foo Lisa Y | EVP, Chief Operating Officer | open-market sale | 10,000 | $258.03 | $3M | 32,053 | Jul 31, 2026 |
| Jul 27, 2026 | Lynch Christopher S. | Director | open-market sale | 3,837 | $243.44 | $934K | 9,568 | Jul 28, 2026 |
| Jul 27, 2026 | Arbour Paola M | EVP, Chief Information Officer | open-market sale | 10,878 | $243.90 | $3M | 18,413 | Jul 28, 2026 |
| Jul 27, 2026 | Bierman James L | Director | open-market sale | 5,000 | $244.96 | $1M | 31,604 | Jul 28, 2026 |
| May 28, 2026 | Kerrey J Robert | Director | open-market sale | 1,969 | $173.12 | $341K | 20,473 | May 29, 2026 |
| May 28, 2026 | Kerrey J Robert | Director | open-market sale | 1,690 | $173.97 | $294K | 18,783 | May 29, 2026 |
| May 28, 2026 | Kerrey J Robert | Director | open-market sale | 713 | $175.13 | $125K | 18,070 | May 29, 2026 |
| May 28, 2026 | Kerrey J Robert | Director | open-market sale | 905 | $176.89 | $160K | 17,165 | May 29, 2026 |
| May 28, 2026 | Kerrey J Robert | Director | open-market sale | 361 | $177.52 | $64K | 16,804 | May 29, 2026 |
| May 27, 2026 | West Nadja | Director | open-market sale | 3,000 | $177.35 | $532K | 24,805 | May 28, 2026 |
| May 22, 2026 | Bierman James L | Director | option exercise | 1,333 | — | — | 36,604 | May 26, 2026 |
| May 22, 2026 | Lynch Christopher S. | Director | option exercise | 1,333 | — | — | 13,405 | May 26, 2026 |
| May 22, 2026 | West Nadja | Director | option exercise | 1,333 | — | — | 28,298 | May 26, 2026 |
| May 22, 2026 | West Nadja | Director | disposition to issuer | 493 | $173.78 | $86K | 27,805 | May 26, 2026 |
| May 22, 2026 | Romo Tammy | Director | option exercise | 1,333 | — | — | 36,199 | May 26, 2026 |
| May 22, 2026 | Romo Tammy | Director | disposition to issuer | 493 | $173.78 | $86K | 35,706 | May 26, 2026 |
| May 22, 2026 | Fisher Richard W | Director | option exercise | 1,333 | — | — | 10,125 | May 26, 2026 |
| May 22, 2026 | Fisher Richard W | Director | disposition to issuer | 493 | $173.78 | $86K | 9,632 | May 26, 2026 |
| May 22, 2026 | Fitzgerald Meghan | Director | option exercise | 1,333 | — | — | 17,580 | May 26, 2026 |
| May 22, 2026 | Fitzgerald Meghan | Director | disposition to issuer | 493 | $173.78 | $86K | 17,087 | May 26, 2026 |
| May 22, 2026 | Agarwala Vineeta | Director | option exercise | 1,333 | — | — | 4,446 | May 26, 2026 |
| May 22, 2026 | Haney Cecil D | Director | option exercise | 1,333 | — | — | 14,346 | May 26, 2026 |
| May 22, 2026 | Haney Cecil D | Director | disposition to issuer | 493 | $173.78 | $86K | 13,853 | May 26, 2026 |
| May 22, 2026 | Mark Richard J | Director | option exercise | 1,333 | — | — | 35,614 | May 26, 2026 |
| May 22, 2026 | Mark Richard J | Director | disposition to issuer | 493 | $173.78 | $86K | 35,121 | May 26, 2026 |
| May 22, 2026 | Kerrey J Robert | Director | option exercise | 1,643 | — | — | 23,049 | May 26, 2026 |
| May 22, 2026 | Kerrey J Robert | Director | disposition to issuer | 607 | $173.78 | $105K | 22,442 | May 26, 2026 |
| May 22, 2026 | Blunt Roy | Director | option exercise | 1,333 | — | — | 5,682 | May 26, 2026 |
| May 22, 2026 | Blunt Roy | Director | disposition to issuer | 493 | $173.78 | $86K | 5,189 | May 26, 2026 |
| Mar 11, 2026 | Arbour Paola M | EVP, Chief Information Officer | open-market sale | 6,500 | $238.43 | $2M | 29,291 | Mar 13, 2026 |
| Mar 9, 2026 | Arnst Thomas W | EVP, Chief Admin. Officer & GC | open-market sale | 4,714 | $238.42 | $1M | 3,298 | Mar 10, 2026 |
| Mar 9, 2026 | Arnst Thomas W | EVP, Chief Admin. Officer & GC | open-market sale | 3,286 | $239.46 | $787K | 12 | Mar 10, 2026 |
| Mar 2, 2026 | Ramsey R. Scott | Principal Accounting Officer | open-market sale | 1,398 | $233.69 | $327K | 0 | Mar 3, 2026 |
| Mar 2, 2026 | Ramsey R. Scott | Principal Accounting Officer | open-market sale | 2,125 | $230.98 | $491K | 5,892 | Mar 3, 2026 |
Who the insiders are
Everyone who reported a transaction since November 1, 2024, by open-market value over twelve months. Shares held are after the insider’s latest directly held transaction.
| Insider | Role | Last transaction | Kind | Shares held | Bought, 12 months | Sold, 12 months | Sales under a plan |
|---|---|---|---|---|---|---|---|
| Sutaria Saumya | CEO, Director | Aug 25, 2026 | open-market sale | 466,344 | — | $28M (5) | 0 of 5 |
| Foo Lisa Y | EVP, Chief Operating Officer | Aug 31, 2026 | open-market sale | 8,053 | — | $9M (2) | 0 of 2 |
| Arnst Thomas W | EVP, Chief Admin. Officer & GC | Mar 9, 2026 | open-market sale | 3,298 | — | $8M (3) | 0 of 3 |
| Romo Tammy | Director | Aug 7, 2026 | open-market sale | 28,284 | — | $8M (8) | 0 of 8 |
| Ramsey R. Scott | Principal Accounting Officer | Mar 2, 2026 | open-market sale | 0 | — | $5M (6) | 0 of 6 |
| Arbour Paola M | EVP, Chief Information Officer | Jul 27, 2026 | open-market sale | 18,413 | — | $4M (2) | 0 of 2 |
| Kerrey J Robert | Director | Sep 14, 2026 | open-market sale | 11,321 | — | $4M (8) | 0 of 8 |
| Mark Richard J | Director | Sep 10, 2026 | open-market sale | 25,121 | — | $3M (1) | 0 of 1 |
| West Nadja | Director | Sep 2, 2026 | open-market sale | 23,653 | — | $1M (3) | 0 of 3 |
| Bierman James L | Director | Jul 27, 2026 | open-market sale | 31,604 | — | $1M (1) | 0 of 1 |
| Lynch Christopher S. | Director | Jul 27, 2026 | open-market sale | 9,568 | — | $934K (1) | 0 of 1 |
| Haney Cecil D | Director | Aug 28, 2026 | gift | 12,403 | — | $361K (1) | 0 of 1 |
| Blunt Roy | Director | Aug 5, 2026 | open-market sale | 4,589 | — | $158K (1) | 0 of 1 |
| Park Sun | EVP & Chief Financial Officer | Feb 27, 2026 | tax withholding | 21,423 | — | — | — |
| Fisher Richard W | Director | May 22, 2026 | option exercise | 10,125 | — | — | — |
| Fitzgerald Meghan | Director | May 22, 2026 | option exercise | 17,580 | — | — | — |
| Agarwala Vineeta | Director | May 22, 2026 | option exercise | 4,446 | — | — | — |
| Rusckowski Stephen H | Director | May 23, 2025 | option exercise | 5,233 | — | — | — |
Questions
Are Tenet Healthcare Corporation New insiders buying or selling?
Over the twelve months to November 1, 2026, 13 insiders at Tenet Healthcare Corporation New sold $71M of stock in the open market, all by officers and directors, and no insider bought. Net, insiders sold $71M. Only open-market purchases and sales are counted.
Who sold the most Tenet Healthcare Corporation New stock in the last year?
Sutaria Saumya (CEO, Director) sold $28M in 5 open-market sales over the twelve months to November 1, 2026.
Do Tenet Healthcare Corporation New executives sell under 10b5-1 plans?
0 of the 42 open-market sales in the last twelve months (0%) were reported as made under a Rule 10b5-1 trading plan, set up in advance. A sale under a plan is still counted as a sale.
What counts as insider buying here?
Only open-market purchases (Form 4 code P) and sales (code S) by officers, directors and 10% owners. Stock awards, option exercises, shares withheld for tax and gifts are listed in the table but never counted as buying or selling.
More on Tenet Healthcare Corporation New
- Tenet Healthcare Corporation New financial statements
- Insider buying and selling across all companies
- These transactions as JSON
From Form 4, 4/A and 5 filings with the SEC. A record of insider transactions, not a recommendation.